Skip to main content

Ventas Value Stock - Dividend - Research Selection

Ventas

ISIN: US92276F1003 , WKN: 878380

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to ?Ventas? or the ?Company? mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


RBC Capital Maintains Outperform on Ventas, Raises Price Target to $99

2026-08-14
RBC Capital analyst Michael Carroll maintains Ventas (NYSE:VTR) with a Outperform and raises the price target from $98 to $99.

National Health Investors: Buy The Earnings Dip And Lock In A 5.3% Yield

2026-08-12
National Health Investors, Inc. near 52-week lows: 5.3% yield, discounted P/FFO, SHOP growth catalyst, and rising dividend outlook. Click for this NHI update.

Top Research Reports for Meta, Texas Instruments & CrowdStrike

2026-08-11
Meta's AI expansion across apps faces margin pressure and uncertain monetization, while WhatsApp and AI glasses add new avenues.

Tuesday's session: top gainers and losers in the S&P500 index

2026-08-11
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.

Discover which S&P500 stocks are making waves on Tuesday.

2026-08-11
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Tuesday's session: gap up and gap down stock in the S&P500 index

2026-08-11
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Tuesday and stay ahead of the market trends.

BMO Capital Maintains Outperform on Ventas, Raises Price Target to $107

2026-08-11
BMO Capital analyst John Kim maintains Ventas (NYSE:VTR) with a Outperform and raises the price target from $105 to $107.

Are Wall Street Analysts Bullish on Ventas Stock?

2026-08-10
As Ventas has outperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.

Ventas (VTR) Q2 2026 Earnings Call Transcript

2026-08-08
Senior housing portfolio surges with 16% NOI growth and 300 basis points occupancy gains.

A Hawkish Hold, A Steeper Curve

2026-08-02
REITs lagged as rising long-term yields outweighed exceptionally strong earnings. Click here to read more about the real estate market here.